TABLE 2.
Comparison of average male pupal survival (assuming 1:1 sex ratio), peak pupation, cephalothorax width and adult longevity of OX5034 and WT strains reared under controlled laboratory conditions with and without 4 μg/ml doxycycline (±95% Confidence Intervals).
| Doxycycline concentration | OX5034 | Wild-type | ||
|---|---|---|---|---|
| 4 μg/ml | 0 μg/ml | 4 μg/ml | 0 μg/ml | |
| MALES | ||||
| Pupal survival from L1 | 68.8% (±6.9) | 74.2% (±8.6) | 70.4% (±3.5) | 66.8% (±3.5) |
| Age at peak pupation (days) | 9 (% pupation on this day = 36.8% ± 2.27) | 8 (% pupation on this day = 59.8% ± 8.93) | 9 (% pupation on this day = 41.8% ± 7.58) | 9 (% pupation on this day = 38.6 ± 3.20) |
| Average cephalothorax width (mm) | 1.10 (±0.007) | 1.01 (±0.009) | 1.11 (±0.006) | 1.09 (±0.007) |
| Median longevity (days) | 39 (95% CI: 35–45 days) | 24 (95% CI: 19–32 days) | 39 (95% CI: 35–50 days) | 49 (95% CI: 45–57 days) |